Thermally modified microbial-derived cellulose for in vivo implantation
US8198261B2 · kind B2 · utility
2Cited by
10References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 18, 2004 |
| Grant date | Jun 12, 2012 |
| Priority date | — |
| Expiry date | Dec 3, 2026 |
Classification
- Technology area (CPC D)Textiles; Paper
- CPC primaryD21C5/005
- WIPO fieldMacromolecular chemistry, polymers
- WIPO sectorChemistry
Abstract
A thermally modified microbial-derived cellulose material is described for use as an implantable material in general surgery, plastic surgery and neurosurgery.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.